BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16008652)

  • 21. A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
    Thomas A; Nagarajan M; Chandrasekaran V; Hari L; Somasundaram PR; Prabhakar R; Kumar A; Bhatia VN; Roy RG
    Indian J Lepr; 1988 Oct; 60(4):499-505. PubMed ID: 3075630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does clofazimine have a prophylactic role against neuritis?
    Arunthathi S; Satheesh KK
    Lepr Rev; 1997 Sep; 68(3):233-41. PubMed ID: 9364824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leprosy: identification of an isolated case].
    Fernández Galán MA; Borbujo Martínez J; Fernández Capitán MC; Casado Jiménez M
    Rev Clin Esp; 1992 Jan; 190(1):24-6. PubMed ID: 1546198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V; Rao MK
    Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of relapsed borderline-lepromatous (BL) leprosy following 27 months of multiple drug therapy, Bhutan.
    Reimer DE; Andersen SM
    Lepr Rev; 1995 Jun; 66(2):183. PubMed ID: 7637531
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of leprosy patients with single lesions to MDT.
    Katoch K; Natrajan M; Yadav VS; Bhatia AS
    Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multibacillary leprosy presenting as a solitary skin lesion; report of three cases and its significance in control programs.
    Ramesh V; Saxena U; Misra RS; Mukherjee A; Ravi S
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):1-4. PubMed ID: 2030305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous sarcoidosis masquerading as relapsed borderline tuberculoid leprosy?
    Kaur S; Dhar S; Bambery P; Kanwar AJ; Khajuria A
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):455-8. PubMed ID: 8228445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of type 1 reaction in multibacillary Hansen's disease as a result of treatment with cyclosporine.
    Frankel RI; Mita RT; Kim R; Dann FJ
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):8-12. PubMed ID: 1602196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects and therapy of early lepromatous leprosy with a case example].
    Becker D; Bräuninger W
    Hautarzt; 1994 Dec; 45(12):845-8. PubMed ID: 7843963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
    Chin-a-Lien RA; Altes-Levy HR; Naafs B
    Br J Dermatol; 1994 Nov; 131(5):720-1. PubMed ID: 7999609
    [No Abstract]   [Full Text] [Related]  

  • 38. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination chemotherapy in leprosy].
    Leiker DL
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.